You are here

Pharma CEOs

Sprout's old CEO is back, and she's got some new marketing ideas for female libido drug Addyi

Sprout's old CEO is back, and she's got some new marketing ideas for female libido drug Addyi

Fierce Pharma

Sprout Pharmaceuticals

Cindy Whitehead

Flag link:

Roche CEO Severin Schwan isn’t about to tamper with a winning R&D strategy now, but he’s still looking for ways to cut costs

Roche CEO Severin Schwan isn’t about to tamper with a winning R&D strategy now, but he’s still looking for ways to cut costs

Endpoints

Flag link:

Old CEO, new chairman? Some Allergan investors want Pyott to come back: report

Old CEO, new chairman? Some Allergan investors want Pyott to come back: report

Fierce Pharma

Flag link:

Portola Pharma CEO Bill Lis Plans to Retire from Company, Board

Portola Pharma CEO Bill Lis Plans to Retire from Company, Board

Xconomy

Portola Pharmaceuticals

Flag link:

Takeda CEO Sees Path to Survival in Shire Megadeal

Takeda CEO Sees Path to Survival in Shire Megadeal

Bloomberg

Flag link:

Former Novartis CEO Explains Why His Company Paid Trump Lawyer Michael Cohen $1.2 Million

Former Novartis CEO Explains Why His Company Paid Trump Lawyer Michael Cohen $1.2 Million

Forbes

Flag link:

Novartis CEO Vas Narasimhan faces a heap of burning questions — but so far offers no public answers

Novartis CEO Vas Narasimhan faces a heap of burning questions — but so far offers no public answers

Endpoints

Flag link:

Akari CEO Abruptly Resigns Following Abuse of Corporate Credit Card

Akari CEO Abruptly Resigns Following Abuse of Corporate Credit Card

BioSpace

Akari Therapeutics

David Horn Solomon

Flag link:

‘Not a good day for Novartis’: CEO tries to reassure employees amid fury over payments to Trump’s lawyer

‘Not a good day for Novartis’: CEO tries to reassure employees amid fury over payments to Trump’s lawyer

Stat

Vasant Narasimham

Flag link:

Drugmaker Novartis plays down its deal with Trump’s lawyer, tying it to its former CEO

Drugmaker Novartis plays down its deal with Trump’s lawyer, tying it to its former CEO

Marketwatch

Vasant Narasimham

Flag link:

No need for a megadeal, Pfizer CEO says. We'll grow despite looming Lyrica generics

No need for a megadeal, Pfizer CEO says. We'll grow despite looming Lyrica generics

Fierce Pharma

Flag link:

Saunders: All options remain on the table for Allergan

Saunders: All options remain on the table for Allergan

Biopharma Dive

Flag link:

Biotech stars Schleifer and Yancopoulos share $52M in 2017 compensation, even though Regeneron’s share price swooned

Biotech stars Schleifer and Yancopoulos share $52M in 2017 compensation, even though Regeneron’s share price swooned

Endpoints

George Yancopoulos

Flag link:

Novartis CEO Vas Narasimhan is raising the bar on second-gen cancer drug studies

Novartis CEO Vas Narasimhan is raising the bar on second-gen cancer drug studies

Endpoints

Flag link:

How big is too big for a CEO bonus target? Annoyed Shire investors have some ideas

How big is too big for a CEO bonus target? Annoyed Shire investors have some ideas

Fierce Pharma

Flemming Ornskov

Flag link:

Novartis CEO: How To Create Cheaper Alternatives To The Most Expensive Drugs

Novartis CEO: How To Create Cheaper Alternatives To The Most Expensive Drugs

Forbes

Vasant Narasimham

Flag link:

Hopes rise for Shire sale as Takeda CEO discusses case for deal

Hopes rise for Shire sale as Takeda CEO discusses case for deal

NASDAQ.com

Christophe Weber

Flag link:

Which Big Pharma CEOs Least Deserved Their Big Pay Increases?

Which Big Pharma CEOs Least Deserved Their Big Pay Increases?

Motley Fool

Bristol-Myers Squibb

Gilead Sciences

Flag link:

After 2016's monster bonus—and investor complaints—Valeant CEO's pay crashes from $62M to $5M

After 2016's monster bonus—and investor complaints—Valeant CEO's pay crashes from $62M to $5M

Fierce Pharma

Valeant Pharmaceuticals

Flag link:

Teva joins the executive pay big leagues after doling out $17M to new CEO Kare Schultz

Teva joins the executive pay big leagues after doling out $17M to new CEO Kare Schultz

Fierce Pharma

Teva Pharmaceutical

Flag link:

Pages